title: Salmonella septic arthritis following total knee arthroplasty for rheumatoid arthritis in a patient receiving etanercept.
authors.affiliation: Department of Orthopaedic Surgery, Kansai Medical University, 2-3-1 Shinmachi, Hirakata, Osaka, 573-1191, Japan. oeken@hirakata.kmu.ac.jp
authors.forename: Kenichi
authors.initials: K
authors.lastname: Oe
authors.forename: Takahiko
authors.initials: T
authors.lastname: Wada
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Ohno
authors.forename: Taketoshi
authors.initials: T
authors.lastname: Kushida
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Iida
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000188:drug therapy* / Q000382:microbiology; D001172:Arthritis, Rheumatoid / Q000188:drug therapy / Q000601:surgery*; D019645:Arthroplasty, Replacement, Knee; D000068800:Etanercept; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007719:Knee Joint; D008297:Male; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D012477:Salmonella enteritidis / Q000302:isolation & purification*; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept